Figure 2.
Figure 2. Isobolograms for the effects of SU11248 and cytarabine on cellular proliferation. Cells were incubated with cytarabine, SU11248, or both for 72 hours and proliferation was assessed using an XTT-based assay. Results were analyzed using Calcusyn software for (A) MV4-11, (B) MOLM14, (C) BAF3 ITD FLT3, (D) FL-stimulated BAF3 WT FLT3, and (E) BAF3 D835V FLT3 cell lines (concentrations of agents are expressed in nM). For 90% inhibition (ED90), the points fall to the left of the predicted line of additive effect, suggesting a synergistic interaction of cytarabine and SU11248. The drugs appear to have an additive effect for doses necessary to inhibit proliferation at 50% of untreated control. • indicates ED50; ▪, ED75; and ▾, ED90. See Table 1 for CI values.

Isobolograms for the effects of SU11248 and cytarabine on cellular proliferation. Cells were incubated with cytarabine, SU11248, or both for 72 hours and proliferation was assessed using an XTT-based assay. Results were analyzed using Calcusyn software for (A) MV4-11, (B) MOLM14, (C) BAF3 ITD FLT3, (D) FL-stimulated BAF3 WT FLT3, and (E) BAF3 D835V FLT3 cell lines (concentrations of agents are expressed in nM). For 90% inhibition (ED90), the points fall to the left of the predicted line of additive effect, suggesting a synergistic interaction of cytarabine and SU11248. The drugs appear to have an additive effect for doses necessary to inhibit proliferation at 50% of untreated control. • indicates ED50; ▪, ED75; and ▾, ED90. See Table 1 for CI values.

Close Modal

or Create an Account

Close Modal
Close Modal